CATHERINE STONE: Open Payments
NPI 1023600293 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$672 in 33 payments from 12 companies in 2025. Trend: 2023 $1,536 · 2024 $991 · 2025 $672
Food & beverage: $672
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $105 |
| ABBVIE INC. | 6 | $103 |
| Sumitomo Pharma America, Inc. | 3 | $79 |
| Novo Nordisk Inc | 4 | $73 |
| GlaxoSmithKline, LLC. | 3 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Lilly USA, LLC | 3 | $48 |
| Exact Sciences Corporation | 2 | $47 |
| Astellas Pharma US Inc | 1 | $32 |
| Edwards Lifesciences Corporation | 1 | $26 |
Products named: GEMTESA, SHINGRIX, ELIQUIS, QULIPTA, Ozempic, AIRSUPRA, VRAYLAR, MOUNJARO.
Industry payments across SC — which companies pay providers there.
